33 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
additional capital;
risks and uncertainties associated with shutdowns or delays caused by the COVID-19 pandemic; and
other factors beyond the Company’s
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
and assess the impact COVID-19 will have on its business activities. The extent of the effect of COVID-19 pandemic on the Company is uncertain
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
capital;
risks and uncertainties associated with shutdowns or delays caused by the COVID-19 pandemic; and
other factors beyond the Company’s control
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
28 Jul 22
Current report (foreign)
2:52pm
NEWS RELEASE
RepliCel’s Manufacturing Inspected by Japan’s PMDA
After over a year of pandemic-related delays, representatives of Japan’s PMDA
6-K
EX-99.4
59qemua7 30yplz
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
qikgr4stso7
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
3hyslkrkna70ucqv vl4
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
e5qd q59o5
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
zqyd4rg be2ohvhrs
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
cuap1kiim u6py
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.5
au7ow bssro91jmw25
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
pylh5l7d8 ow
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.3
wlakamn m1015chere
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
dm3tp 7ciwu3c1
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
spmoem8joc0q1 obkw
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm